Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-20T07:20:07.919Z Has data issue: false hasContentIssue false
  • English
  • Français

Transcranial magnetic stimulation for depression and other psychiatric disorders

Published online by Cambridge University Press:  01 October 2001

B. McNAMARA ,
J. L. RAY ,
O. J. ARTHURS  and
S. BONIFACE
B. McNAMARA
Affiliation:
From the Cambridge Transcranial Magnetic Stimulation Group, Department of Clinical Neurophysiology, Addenbrooke's Hospital, Cambridge
J. L. RAY
Affiliation:
From the Cambridge Transcranial Magnetic Stimulation Group, Department of Clinical Neurophysiology, Addenbrooke's Hospital, Cambridge
O. J. ARTHURS
Affiliation:
From the Cambridge Transcranial Magnetic Stimulation Group, Department of Clinical Neurophysiology, Addenbrooke's Hospital, Cambridge
S. BONIFACE
Affiliation:
From the Cambridge Transcranial Magnetic Stimulation Group, Department of Clinical Neurophysiology, Addenbrooke's Hospital, Cambridge
Get access Rights & Permissions [Opens in a new window]

Abstract

Introduction. Repetitive transcranial magnetic stimulation (rTMS) has been proposed as a possible alternative to electroconvulsive therapy for the treatment of selected patients with depression, bipolar affective disorder and schizophrenia. The aim of this study was to evaluate the evidence for the effectiveness of rTMS in mood disorders and schizophrenia.

Methods. Studies were identified using MEDLINE (1966 to January 2000), EMBASE/Excerpta Medica (1980 to January 2000), Biological Abstracts and Index to Scientific and Technical Proceedings. A number of biomedical and TMS related websites were also searched. We estimated the number needed to treat to show beneficial effect of rTMS when compared with the placebo controlled group.

Results. Seven controlled trials of rTMS depression were identified. Five of these were suitable for meta-analysis and show a beneficial effect of rTMS compared to placebo, with a number needed to treat of 2·3 with a 95% confidence interval 1·6 to 4·0, total; 81 patients. A single trial of rTMS has also been performed in mania, which shows a beneficial effect of right hemisphere stimulation when compared with left hemisphere stimulation. A controlled trial in schizophrenia failed to show any benefit of rTMS.

Discussion. rTMS has demonstrable beneficial effects in depression. The extent and the duration of the anti-depressant effect of rTMS has yet to be defined. There now needs to be randomized controlled trials to compare rTMS directly with standardized electroconvulsive therapy in order to take this subject forward. With regard to the treatment of other mood disorders and schizophrenia, we are at an early stage in the assessment of further studies that are needed to examine any potential role for rTMS.

Type
REVIEW ARTICLE
Information
Psychological Medicine , Volume 31 , Issue 7 , October 2001 , pp. 1141 - 1146
Copyright
© 2001 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)